Investors should have a “keep calm and carry on” approach to financial markets, maintaining a long position in emerging ...

Novartis’ Cosentyx (secukinumab) has failed to show any benefit in the Phase III study in adults with newly diagnosed or ...

Lunit is collaborating with Microsoft to help bring its AI-powered diagnostics for cancer detection into clinical practice.

With the pull-forward effect ahead of tariff implementation over, the US vehicle market is expected to slow further in H2.

Across 100 patients in three Phase III studies, Vertex's Casgevy showed lasting benefits for more than five years.

Mexico could gain strategic benefits in the current trade environment, as companies look to relocate production within North ...

Spirits companies have reason to be confident on Gen Z but where do they see growth and is developing a targeted approach the right answer?

GlobalData, using its Ai Palette platform, presents the ingredients it believes offer opportunities for confectioners to win over snack lovers.

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is poised to grow at a compound annual growth rate (CAGR) ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis portfolio.

War risk cover, once a niche product, is re-emerging as a critical discussion point,' says data and analytics firm ...

The Chinese government is signaling enough is enough when it comes to the fierce competition in the country’s electric car ...